Pharmaceutical Department
Technology Property-Managing the Future
¡@¡@Sinon Co. established a pharmaceutical R&D center and Syn-Tai Pharmaceutical Co., Ltd. in 1996. We are working in key technology development
of drug intermediates, raw material synthesis, bio-chemical engineering R&D, pilot scale and production scale up.
¡@¡@The Department has obtained key technologies in condensation, hydrogenation, chlorination, sulfonation, amination, alkylation, coupling, dehydration,
asymmetrical synthesis, separation, crystallization, fermentation and quality assurance. We also own a core technology of R&D and a team of professional
trained specialists in developing raw material and intermediates for drugs treating hypertension, cholesterol, ulcer, fugal, cancer, diabetic, asthma and depression. Especially,
we are focusing on production and market development of drugs used for cardiac vascular, nervous, and gastrointestinal systems and the quality meets a high
standard requirement from our international customers. In the meantime, we are also working with multi-national pharmaceutical companies and trading companies
in jointly developing and manufacturing top level technology pharmaceutical intermediates and specialty chemicals.
|